Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chiron Fluvirin production

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

Chiron expects a full production season in 2006-2007 of 40 mil. doses for its influenza vaccine Fluvirin, the firm says Oct. 17. The company reports it has shipped 1.5 mil. doses of this year's formulation so far but that production for the full 2005-2006 season will be lower than previously expected. Chiron says it will not provide revised total production estimates for the current season. FDA released three lots of Fluvirin Sept. 14 (1Pharmaceutical Approvals Monthly October 2005, p. 16). "Despite Chiron's lowered projections announced today, we still anticipate that there will be significantly more vaccine produced than last year," FDA said in a same-day press release...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS003100

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel